Structure–Activity relationships of oxime neurokinin antagonists: oxime modificationsGregory A Reichard; James Spitler; Robert Aslanian; Mwangi wa Mutahi; Neng-Yang Shih; Ling Lin; Pauline C Ting; John C Anthes; John J Piwinski · 2002

The design and synthesis of novel NK1/NK2 dual antagonistsGregory A Reichard; Zachary T Ball; Robert Aslanian; John C Anthes; Neng-Yang Shih; John J Piwinski · 2000

A Novel Pyrrolidine Analog of Histamine as a Potent, Highly Selective Histamine H3 Receptor AgonistShih, Neng-Yang; Lupo, Andrew T.; Aslanian, Robert; Orlando, Steven; Piwinski, John J.; Green, Michael J.; Ganguly, Ashit K.; Clark, Michael A.; Tozzi, Salvatore · Journal of Medicinal Chemistry · 1995

An asymmetric synthesis of the novel H3 agonist (+)-(3R,4R)-3-(4-imidazolyl)-4-methylpyrrolidine dihydrochloride (Sch 50971)Robert Aslanian; Gary Lee*; Radha V Iyer; Neng-Yang Shih; John J Piwinski; Richard W Draper; Andrew T McPhail · 2000

Sulfonamides: a patent review (2008 – 2012)Carta, Fabrizio; Scozzafava, Andrea; Supuran, Claudiu T · Expert Opinion on Therapeutic Patents · 2012

Related articlesPant, M.; Ang, L. K. · Expert Opinion on Therapeutic Patents · 2012

Annotated Patent SelectionsLee, Dongwon; Dasari, Madhuri; Erigala, Venkata; Murthy, Niren; Yu, Junhua; Dickson, Robert · Expert Opinion on Therapeutic Patents · 2007

Elastase inhibitorsExpert Opinion on Therapeutic Patents · 2004

AMPA receptor antagonistsChimirri, Alba; Gitto, Rosaria; Zappalà, Maria · Expert Opinion on Therapeutic Patents · 1999

Small molecules for stem cellsKochegarov, Andrei · Expert Opinion on Therapeutic Patents · 2009

Small molecules for bone diseasesMasuya, Keiichi; Teno, Naoki · Expert Opinion on Therapeutic Patents · 2010

Cathepsin K inhibitors, 2000 – 2004Cai, Jiaqiang; Jamieson, Craig; Moir, Jennifer; Rankovic, Zoran · Expert Opinion on Therapeutic Patents · 2005